Clinical trial

Study Evaluating Efficacy and Safety of PF-04523655 Versus Laser in Subjects With Diabetic Macular Edema

NCT00701181

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2008-06-01

PhasePHASE2

Study timeline

Study start (unknown)2008-06-01Date precision: month

Registry last updated2012-10-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetic Retinopathyunresolved

Diabetes Complicationsunresolved

Interventions

Laser TreatmentPROCEDURE

PF-04523655 highDRUG

PF-04523655 middleDRUG

PF-04523655 lowDRUG

Sponsors & collaborators

Quark Pharmaceuticalslead sponsor

Pfizercollaborator

Mapped research locations

MilanItaly3 BostonMassachusetts, United States2 PhoenixArizona, United States2 RomaItaly2 BristolUnited Kingdom2 ChicagoIllinois, United States1 BaltimoreMaryland, United States1 IndianapolisIndiana, United States1 Las VegasNevada, United States1 CharlotteNorth Carolina, United States1 Winston-SalemNorth Carolina, United States1 LeipzigGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00701181 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.